). The present aims were to determine whether the actin cytoskeleton of synovial endothelium, fibroblasts, and synoviocytes influences in vivo (i) fluid exchange between a joint cavity and synovial microcirculation and (ii) extracellular fluid pressures in joints. Rabbit knee joints were treated intra-articularly with the Factin disrupting drugs cytochalasin D and latrunculin B while joint fluid pressure P j was recorded. In joints injected with small volumes of control solution, P j fell with time (؊0.05 ؎ 0.01 cm H 2 O min ؊1 , mean ؎ SEM, n ‫؍‬ 9, equivalent drainage rate 3.9 l min ؊1 ). Cytochalasin or latrunculin reversed this in ϳ4 min in vivo; P j increased with time, e.g., ؉0.12 ؎ 0.04 cm H 2 O min ؊1 at 200 M cytochalasin (equivalent filtration rate into joint 6.6 -12.5 l min ؊1 , n ‫؍‬ 4), with a cytochalasin EC 50 of 45 M. Plasma ␥-globulin clearance into the joint cavity was also increased. Post mortem, cytochalasin did not reverse dP j /dt and had no more effect on P j than did control solution. Also, when synovial interstitial fluid pressures were measured by servonull micropipette post mortem (control ؊0.95 ؎ 0.37 cmH 2 O, n ‫؍‬ 18) cytochalasin had no significant effect on interstitial pressure over 60 min, even at 1 mM. It was concluded that synovial endothelial F-actin has an important role in the normal synovial microvascular resistance to fluid filtration and plasma ␥-globulin permeation and is thus a potential link between pro-in- 
INTRODUCTION
Synovium is a thin, mesenchyme-derived sheet of tissue responsible for the generation, encapsulation, and drainage of synovial fluid in joints. A superficial network of fenestrated microvessels filters fluid slowly into the joint cavity when intra-articular pressure is low, as in extended joints. In synovitis a breakdown of the endothelial barrier leads to the development of a protein-rich effusion in the joint cavity (Wallis et al., 1987) . When synovial fluid pressure is raised, e.g., by flexion, the net trans-synovial flow reverses direction and fluid is driven out of the joint cavity. The fluid passes between the discontinuous synoviocytes (specialized fibroblasts; Edwards, 1999) that line the surface and drains into a subsynovial lymphatic system. The intersynoviocyte pathway comprises a matrix of types I, III, IV, V, and VI colla-gen, hyaluronan, sulfated proteoglycans, and fibronectin , and its level of hydration is an important factor influencing its permeability.
Our interest in the role of filamentous actin (F-actin) in synovial cells arose from reports that F-actin in fibroblasts modulates the interstitial fluid pressure and hydration of rat skin (Reed et al., 1997; Berg et al., 2001) . F-actin is a ubiquitous cytoskeletal microfilament that is present in endothelium (see below), fibroblasts (Ribeiro et al., 1997) , and their close relatives, the synoviocytes that line a joint cavity (Ward et al., 1999) . The F-actin is linked to the extracellular matrix through membrane integrins (Takenaga et al., 1990) . In endothelium, the actin microfilaments also link with the intercellular junction protein complex (Dejana et al., 1995) . The work of Reed's group, using servonull micropipettes to measure pressure, indicated that the fibroblast cytoskeleton exerts a tonic tension on interstitial collagen through ␣ 2 ␤ 1 -integrins, thereby opposing the interstitial glycosaminoglycan swelling pressure and the innate tendency of the tissue to hydrate. Disruption of this equilibrium, using antibodies against ␣ 2 ␤ 1 -integrin or the F-actin disrupting agent cytochalasin, caused interstitial fluid pressure to fall to more subatmospheric values over 30 -60 min, due to expression of the unopposed gel swelling pressure. In synoviocytes the cytoskeleton is likewise linked to the extracellular matrix by ␤ 1 integrins (Rinaldi et al., 1997) and to hyaluronan through CD44 (Lacy and Underhill, 1985; Henderson et al., 1993; Asari et al., 1995) . One aim, therefore, was to investigate whether synoviocyte F-actin influences extracellular fluid pressures in joints.
The negative pressure responses described by Reed's group were clearly demonstrated only post mortem, when circulatory stasis prevents a secondary rise in interstitial hydration. In vivo, by contrast, cytochalasin caused increases in the hydration and the albumin content of rat dermis, indicating that F-actin also contributes to endothelial barrier function in rat skin (Berg et al., 2001) . This is in keeping with studies of continuous endothelium monolayers in vitro, which show that cytochalasin disrupts phalloidin-labeled microfilaments and causes cell retraction, intercellular gap formation, and a raised permeability (Shasby et al., 1982; Alexander et al., 1988; Haselton et al., 1989; Holda and Blatter, 1997; Kevil et al., 1998) . Moreover, changes in F-actin distribution and disruption of the peripheral F-actin ring are features of inflammation in venular endothelium (Baldwin and Thurston, 1995; Ehringer et al., 1999) . In vivo, intravascular cytochalasin causes edema, a fall in the albumin reflection coefficient, and a rise in the microvascular filtration capacity (Shasby et al., 1982; Korthuis et al., 1991; Ermert et al., 1995) . In view of the above findings, a second aim was to investigate whether F-actin influences the movement of fluid across the fenestrated capillaries of synovium and hence whether it has a potential role in the formation of joint effusions.
The above aims were addressed by experiments using two F-actin disrupting drugs. Cytochalasin D is a fungal metabolite that disrupts actin microfilaments in minutes, primarily by capping the barbed, growing end of the actin filament. Actin filaments are dynamic structures that undergo a continuous, rapid, treadmilltype turnover, in which monomeric G-actin is continuously removed from one end and added to the opposite end at a rate of Ͼ4.5 m min Ϫ1 (Symons and Mitchison, 1991; Alberts et al., 1994) . Blockage of the growing end by cytochalasin is thus quickly followed by filament disassembly. Rapid disassembly of F-actin has been confirmed both in endothelium (Holda and Blatter, 1997; Wang, 1998) and in fibroblasts (Ribeiro et al., 1997) . Additional mechanisms may contribute to F-actin disruption at high drug concentrations (Cooper, 1987) .
To confirm the specificity of cytochalasin D-induced effects, we also carried out experiments with latrunculin B, a Red Sea sponge toxin that inhibits F-actin polymerization by a different mechanism. Latrunculin binds to the cytosolic pool of G-actin and thus reduces its availability, which leads to disruption of the rapidly turning over F-actin microfilaments (Spector et al., 1983; Coué et al., 1987; de Oliveira and Mantovani, 1988) .
METHODS
In an initial series of experiments in vivo, F-actin disrupting drug was injected into the joint cavity of rabbit knees under anesthesia and resulting changes in joint fluid pressure (P j ) were recorded through a cannula for 30 min. A fall in pressure indicated net drainage of fluid from the cavity, whereas a rise indicated net filtration into the cavity. The experiment was repeated on the contralateral joint using a control solution or low dose of drug. The pressure response in the joint cavity to cytochalasin D was also studied post mortem. The reasoning behind the latter study was that any increase in the swelling tendency of synovial interstitium will cause the absorption of some intraarticular fluid post mortem and thus be revealed by a fall in articular fluid pressure. In a second series of experiments, designed to reproduce closely the servonull micropipette method of Berg et al. (2001) , minute boluses of drug at various concentrations were injected directly into the exposed synovial tissue post mortem, and interstitial fluid pressure in the adjacent tissue was monitored by a servonull micropipette system for up to 60 min.
Experimental Preparation in Vivo
New Zealand white rabbits weighing 2.5-3 kg were anesthetized with 30 mg kg Ϫ1 sodium pentobarbitone plus 500 mg kg Ϫ1 urethane iv and tracheostomized. Anesthesia was maintained at sufficient depth to abolish the corneal blink reflex using intravenous 15 mg sodium pentobarbitone plus 250 mg urethane every 30 min. Procedures conformed to local animal legislation and animals were killed by an overdose of iv sodium pentobarbitone at the end of the experiment. The intra-articular cannulation and pressure-recording systems were as described by Coleman et al. (1999) .
Intra-articular Injections and Rate of Change of Joint Fluid Pressure, dP j /dt
A 21-gauge cannula was inserted into the joint cavity and connected to a water-calibrated differential pressure transducer to measure P j . A bolus of 150 -400 l of test solution was injected into the joint cavity through the pressure line, raising P j to just above atmospheric pressure, and P j was recorded for 30 min. Since P j is related to the volume of fluid V present in the joint cavity through a known compliance curve Levick, 1982, 1983) , the rate of change of pressure dP j /dt served as a measure of dV/dt, i.e., the net trans-synovial flow (Q s ). Slopes on the chart record were fitted by ruler.
Interstitial Pressure Measurements by the Servonull Micropipette System Post Mortem
The servonull feedback system (Vista Electronics Co., Ramona, CA) utilized changes in electrical resistance in a 1 M NaCl-filled micropipette, caused by minute flows of interstitial fluid through the tip, to control a pump that adjusts the pressure in the micropipette until it balances that of the interstitial fluid. The method has been evaluated by Wiig et al. (1981) . The system used here was as described by Miserocchi et al. (1990) . Briefly, glass micropipettes of outer diameter 1 mm with ground, beveled tips of diameter of 2-5 m were filled with 1 M NaCl, which was colored with lissamine green for tip visualization. The system's P23XL pressure transducer (Gould Instruments, Cleveland, OH) was precalibrated with a water column. The linearity of calibration of each micropipette was checked by inserting it into a sealed chamber of normal saline connected to a second water column. Zero level (atmospheric pressure) was set with the tip touching a small pool of normal saline level with the micropuncture site. Output was recorded on a thermal oscillograph (Gould Instruments).
Interstitial fluid pressures were measured in the synovial lining of joint cavities that were opened immediately after the animal was killed by an anesthetic overdose. A central flap of tissue was raised by means of a transverse incision across the insertion of the patellar tendon, extended proximally by two parallel incisions along the medial and lateral sides of the patellar ligament and patella. The resulting flap was retracted to access the joint cavity. The lateral margin of the joint capsule was then retracted to expose a sheet of lateral suprapatellar synovium. The underside of the retracted tissue was supported by a plasticine mold. The space between the tissue, the microscope objective, and the micropipette was enclosed by a continuous seal of polyvinyl chloride/ethylene film (Cling Film, Woolworths, UK) to maintain local humidity. Superfusion was not used, in order to avoid overhydration of the interstitium prior to the pressure measurements.
After the initial, control measurements of synovial and subsynovial interstitial pressures (see below), 1.5 l of test solution was injected as superficially as possible under the exposed lateral suprapatellar synovium, using a 34-gauge needle and a 10-l Hamilton syringe (Hamilton, Sutton, England), which was held at a shallow angle. Since the needle was thicker than the synovium, the fluid was delivered into the subsynovium rather than the synovium itself. The volume injected was too small to raise a visible surface bleb.
The micropipette was mounted in a MO-102 micromanipulator (Narishige, Tokyo, Japan). After the zero pressure reading was checked with the tip touching the tissue surface, the tip was advanced into the synovium under stereomicroscopic guidance (SMZ-2T stereomicroscope, Nikon, Tokyo, Japan). The vertical depth of the tip was calculated as h ⅐ sin , where was the angle of insertion (ϳ45°) and h the distance advanced obliquely, as read from the micromanipulator scale in micrometers. Since the arithmetic mean thickness of rabbit synovium in the suprapatellar pouch is 16 -19 m, and that of the subsynovium is ϳ100 m (Knight and Levick, 1983; Levick and McDonald, 1989a) , measurements taken at tip depths of Ͻ10 m were classified as synovial interstitial pressures and those at 20 -35 m were classified as subsynovial interstitial pressures. The region between 10 and 20 m was ignored due to the uncertainty over tissue type near the synovium/subsynovium boundary during a blind penetration. After stable pressures were recorded for 10 s or so in the synovium and subsynovium, the micropipette was withdrawn and the zero rechecked. Readings were accepted if the pipette zero reading was the same before and after insertion, and if the tissue surface was not visibly distorted by entry of the micropipette. Changing the gain of the servonull system without a consequent change in recorded pressure provided a further check on the system in control experiments. Pressure measurements were repeated at 10-min intervals for an hour, moving the micropipette tip around the perimeter of the injection site so that each measurement was 10 -15 m from the previous site but equidistant from the injection center.
Measurements were taken at points 1 mm radially from the center of the injection site. The radial distance was marked lightly on the tissue surface at four points at the outset, using another micropipette dipped in a lissamine green solution. The distance selected for measurements represented a compromise between avoiding the central region where pressure was raised by the injection yet remaining within the region reached by the drug. Following the approach of Berg et al. (1998) , measurements were made just beyond the edge of the injected bolus, which would be at 0.7-mm radius for a 1.5-l sphere. A pilot study showed that pressure fell from ϩ7.5 cm H 2 O in the center of the injection site to Ϫ1.5 cm H 2 O at the 1-mm radial distance. Since a small solute such as cytochalasin, with a diffusivity similar to that of glucose, achieves 99% diffusional equilibration across 1 mm in 9.3 min, even when unaided by convection, it was concluded that tissue only ϳ0.3 mm from the edge of the initial bolus will be exposed to drug within minutes of its injection, albeit at subnominal concentrations.
Small Solute Clearance from Joint Cavity
The intra-articular concentration of a small, rapidly diffusible solute such as cytochalasin D (508 Da) must decay with time in vivo due to diffusional clearance into the fenestrated capillaries and periarticular tissue. A preliminary calculation of clearance by the microcirculation predicted a substantial rate of decay, as follows. For flow-limited (i.e., maximal) microvascular clearance by an estimated plasma flow of ϳ40 l min Ϫ1 per knee, the solute half-life would be ϳ17 min in a joint cavity containing 1 ml fluid (corresponding pressure ϳ6 cm H 2 O). To test this experimentally, the clearance of three small, colored solutes was assessed in vivo and post mortem by injecting 1 ml of solution into the joint cavity at time zero and aspirating small aliquots at 8, 16, and 32 min. Solute concentrations were assayed by optical absorbance in a spectrophotometer. The three solutes were acridine orange (370 Da, lipid and water soluble, absorption peak 482 nm), patent blue V (582 Da, water soluble only, absorption peak 636 nm), and Evans blue (963 Da, water soluble only, absorption peak 605 nm). Cytochalasin itself had no convenient absorption maximum for assay.
Plasma Globulin Permeation into Joint Cavity
To assess the transcapillary permeation of native plasma protein into the joint cavity, a pair of joints was infused with 100 M cytochalasin D and control solution, respectively. Fluid was aspirated at 15-min intervals and replaced by fresh solution, and the experiment continued for Ͼ1 h. Aspirates, along with a sample of ear vein plasma, were analyzed for native ␥-globulin by polyacrylamide gel electrophoresis (NuPage Electrophoresis System, Novex Electrophoresis, Frankfurt, Germany). Gels and standards stained with Coomassie blue were read using a Fluor-S MultiImager system (Bio-Rad, Hercules, CA). Net flux of ␥-globulin into the joint cavity was calculated as concentration ϫ intra-articular volume/time.
Materials
Cytochalasin D and latrunculin B were purchased from Calbiochem (Nottingham, UK). Cytochalasin D (1 mg) was dissolved in 0.5 ml dimethyl sulfoxide, which was then added drop by drop to phosphatebuffered saline (pH 7.4) with continuous rapid stirring to prevent precipitation, until the required dilution was reached. The infused concentrations were 0, 1, 10, 25, 50, 100, and 200 M cytochalasin D, each of which was studied in triplicate or more. Due to its high cost, only a limited study was carried out with 1 mM cytochalasin, the concentration studied by Berg et al. (2001) . The broad-spectrum protease inhibitor ␣ 2 -macroglobulin was included in one experiment with 200 M cytochalasin D to test whether activation of tissue protease played any role (Unemori and Werb, 1986 ). Latrunculin was infused at 100 M. Control solutions contained the same concentration of dimethyl sulfoxide as the contralateral test solution. The Ringer solution comprised 147 mM Na ϩ , 4 mM K ϩ , 2 mM Ca 2ϩ , and 156 mM Cl Ϫ at pH 7.2 (Baxter Healthcare Ltd., Thetford, Norfolk, UK).
Statistical Methods
Results were compared using Student's t test or analysis of variance (ANOVA) as appropriate, with P Յ 0.05 considered a significant difference. EC 50 was estimated by fitting a 4-parameter logistic equation (top, bottom, Hill slope, EC 50 ; GraphPad Prism, San Diego, CA) to the logarithmic dose-response curve. Means are followed by their standard errors throughout.
RESULTS

Effect of Cytochalasin on Intra-articular Pressure and Microvascular Filtration in Vivo
When control solution was injected into the joint cavity, raising pressure initially to 1-2 cm H 2 O, P j decayed slowly over the next 30 min (n ϭ 9) (Fig. 1) . The decay is due to drainage of the injected fluid through the synovial interstitial pathway into the subsynovium, where the endogenous fluid pressure is subatmospheric (Scott et al., 2000b) . In marked contrast, when cytochalasin D solution at Ն50 M was injected into the cavity, the normal decay in P j with time ceased within a few minutes and reversed direc-
FIG. 1.
Effect of intra-articular injection of 100 M cytochalasin D or vehicle (Ringer solution containing 2.5% dimethyl sulfoxide) on pressure in contralateral knees of the same animal in vivo. The initial spike was caused by the injection volume, ϳ300 l. In the control joint the pressure then decayed as the injectate drained out through the synovial lining. Cytochalasin halted the decay in 3 min and initiated a rise in intra-articular pressure, indicating the development of an effusion. Measurements of dP j /dt were taken at the time of maximum rate of increase (t max ), ϳ10 min in this case. tion at 4.2 Ϯ 0.9 min (n ϭ 14) (Fig. 1) . Pressure then increased with time, indicating a switch to net transsynovial filtration of fluid into the joint cavity. The pressure gradually climbed higher than the initial spike of P j caused by the injected volume. The rate of rise gradually slowed as P j increased. Even so, in a few joints studied for 1 h, the pressure was still rising slowly at 60 min, despite the fact that P j had reached 6-7 cm H 2 O.
The rate of pressure change dP j /dt depended on the concentration of cytochalasin D (P Ͻ 0.001, one-way ANOVA). Treatment with cytochalasin at Ն50 M reversed dP j /dt to positive values in all cases (P Ͻ 0.05, Bonferroni's test, n ϭ 14), whereas none of the joints treated with 1-10 M cytochalasin showed a reversal of the negative dP j /dt (n ϭ 6). The time at which the rate of pressure rise following Ն50 M cytochalasin was steepest, t max , was ϳ10 min after the injection. The relation between dP j /dt at t max and the logarithm of concentration was sigmoidal (Fig. 2) . Cytochalasin had little effect at 1 M (dP j /dt ϭ Ϫ0.033 Ϯ 0.010 cm H 2 O min Ϫ1 , pressure 0.53 Ϯ 0.09 cm H 2 O, n ϭ 3) or 10 M (dP j /dt ϭ Ϫ0.028 Ϯ 0.010 cm H 2 O min Ϫ1 , pressure 0.30 Ϯ 0.30 cm H 2 O, n ϭ 3), and the effect appeared to approach a maximum by 200 M (dP j / dt ϭ ϩ0.115 Ϯ 0.039 cm H 2 O min Ϫ1 , pressure 4.9 Ϯ 1.0 cm H 2 O, n ϭ 4). In the control joints dP j /dt at times corresponding to t max was Ϫ0.046 Ϯ 0.008 cm H 2 O min Ϫ1 (pressure 0.38 Ϯ 0.27 cm H 2 O, n ϭ 9). The estimated EC 50 was 44.6 M, with 95% confidence intervals of 36 -55 M.
Net trans-synovial flow was calculated as dP j /dt multiplied by the compliance dV/dP j at the corresponding pressure. Compliance values were taken from Knight and Levick (1982) . For the control solution the average trans-synovial drainage rate was 3.9 l min Ϫ1 at times corresponding to contralateral t max . (Drainage is allocated a positive sign for consistency with previous work.) After treatment with 200 M cytochalasin D the trans-synovial flows at t max were in the range Ϫ6.6 to Ϫ12.5 l min Ϫ1 , with the negative sign indicating net filtration into the cavity. Experiments post mortem showed that the microcirculation was responsible for the filtration into the cavity (see below). The effect of cytochalasin in joints was thus to initiate the rapid development of a joint effusion.
Although cytochalasin is known to act directly on endothelium (see Introduction), we also tested whether tissue protease activation might contribute to the response. The broad-spectrum protease inhibitor ␣ 2 -macroglobulin was added to 10 ml of 200 M cytochalasin D in one experiment. The quantity of ␣ 2 -macroglobulin, 1 mg, was sufficient to inhibit Ͼ10 g of trypsin activity or 10 4 BAEE units per milligram of protein. It had no effect, however, on the pressurereversal response to cytochalasin D. Slope dP j /dt reversed direction within 2 min and increased to ϩ0.113 cm H 2 O min Ϫ1 , which is equivalent to a net filtration rate of ϳ11 l min Ϫ1 into the joint cavity.
Effect of Latrunculin B on Intra-articular Pressure in Vivo
In two joints latrunculin B (100 M) was substituted for cytochalasin D in the standard protocol. Within 6 min of the latrunculin injection, P j ceased to fall and began to rise. The rate of pressure increase, 0.033 cm H 2 O min Ϫ1 (mean of two), was equivalent to a net filtration of 3 l min Ϫ1 into the cavity. Since lantrunculin and cytochalasin both disrupt F-actin, but by different mechanisms, the results support the view that reversal of dP j /dt is mediated by the breakdown of actin microfilaments.
Reversibility of Effect of Cytochalasin on Intraarticular Pressure and Filtration
The reversibility of the action of cytochalasin was investigated in three joints. After the effect of a 200-l intra-articular injection of 50 M cytochalasin D on dP j /dt for 30 min was recorded, the cavity was washed out with Ringer solution (3 ϫ 200-l washes) and aspirated. The response of dP j /dt to a 200-l injection of Ringer solution was then recorded for another 30 min (Fig. 3) . Following the initial cytochalasin injection, P j began to rise at ϳ4 min and continued to increase until the washout at 30 min. After the washout and injection of Ringer solution to approximately the same starting pressure, the pressure decayed slowly with time, as in an untreated joint. The cytochalasin-induced positive dP j /dt was thus readily reversed. Rapid reversal of drug action from positive dP j /dt (net filtration) to negative dP j /dt (net drainage) occurred in two joints, while in the third joint there was a partial reversal; i.e., dP j /dt remained positive but its magnitude was much reduced.
Effect of Cytochalasin D on Intra-articular Fluid Pressure Post Mortem
To demonstrate the effect of rat dermal fibroblasts on interstitial fluid pressure, Berg et al. (2001) injected cytochalasin D post mortem; this prevented microvascular filtration from masking an increasing negativity of the interstitial fluid pressure. Since synovial fluid is in direct contact with the synovial interstitium, we looked for an analogous effect by measuring the response of P j to cytochalasin post mortem. Experiments post mortem also tested the inference that the positive dP j /dt after cytochalasin treatment is caused by microvascular filtration. Small volumes (100 -200 l) of 50 -100 M cytochalasin D (n ϭ 5 joints) or 1 mM cytochalasin D (n ϭ 4 joints) or Ringer solution (n ϭ 6 joints) were injected into the joint cavity through the pressure line after cardiac arrest, and changes in P j were followed for 30 -60 min. Figure 4 shows that, in marked contrast to the results in vivo, the effects of 1 mM cytochalasin D and control solution were not significantly different after circulatory arrest. After injection of the drug, P j decayed slowly. The change in P j with time closely paralleled that of the control solution, with P j approaching an asymptote that presumably represented pressure equilibration with the adjacent synovial tissue. Since dP j /dt after cytochalasin was negative post mortem (Fig. 4) yet positive in vivo (Fig. 1) , it is inferred that positive dP j /dt values in vivo depended on synovial microvascular perfusion.
In contrast to the observations of Berg et al. (2001) in rat skin, there was no evidence for the generation of extra negative pressures by cytochalasin in joints post mortem. The mean fall in P j over the 30 min following the injection peak was Ϫ1.26 Ϯ 0.38 cm H 2 O for control solution (n ϭ 6) and Ϫ1.28 Ϯ 0.28 cm H 2 O for cytochalasin D at 50 -1000 M (n ϭ 9). The difference was not significant (P ϭ 0.97, unpaired t test). The fall in P j following injections of cytochalasin D at 1000 M was Ϫ0.71 Ϯ 0.14 cm H 2 O over 30 min (n ϭ 4) and Ϫ0.63 Ϯ 0.24 cm H 2 O over 45 min. Over a similar period Berg et al. (2001) observed a change of approximately Ϫ2.7 cm H 2 O in the cytochalasin-injected rat dermis, in contrast to ϩ0.6 cm H 2 O in saline-injected controls.
To test whether the volume of the injectate, 100 -200 l, might have obscured a developing negativity, the experiment was repeated in four more joints using 10-l injections of 1 mM cytochalasin D delivered from a Hamilton syringe. The results were similar to those in Fig. 4 ; there was no evidence of the induction of increasingly negative pressures by cytochalasin. Mean pressure was Ϫ2.9 Ϯ 2.1 cm H 2 O immediately after the injection and Ϫ2.5 Ϯ 1.4 cm H 2 O at 30 min (P ϭ 0.9, t test).
Effect of Cytochalasin D on Interstitial Fluid Pressure; Servonull Micropipette Results
It could be argued that measurements of P j failed to detect the putative influence of synoviocytes on interstitial fluid pressure because pressure was recorded in a contiguous space rather than in the interstitium itself. Calculations based on the relative compliances of the intra-articular and synovial interstitial compartments indicate that this is unlikely to be the true reason (see Discussion). To address the issue directly, however, we applied the servonull micropipette technique of Berg et al. (2001) to measure the interstitial fluid pressures (P if ) in the synovium and subsynovium post mortem.
Prior to the interstitial injection of test solution, the synovial and subsynovial interstitial pressures were slightly subatmospheric, with average values of Ϫ0.95 Ϯ 0.37 cm H 2 O (n ϭ 18) and Ϫ0.81 Ϯ 0.54 cm H 2 O (n ϭ 18), respectively. Repeated measurements of synovial and subsynovial P if over 60 min in two joints that received no interstitial injections showed no significant change with time; none of the four regression slopes of P if versus time was significantly different from zero (P Ն 0.3), indicating that the tissue hydration was not changing significantly.
The changes in mean P if over 60 min following the injection of 1.5 l of vehicle or 200 -1000 M cytochalasin D are shown in Fig. 5A (synovial P if ) and 5B (subsynovial P if ). Inspection indicated that neither synovial nor subsynovial P if became consistently more subatmospheric in response to cytochalasin D. Analysis of the results for 0, 200, and 500 M cytochalasin D showed no significant relation between P if and time (P ϭ 0.8, two-way ANOVA). Similarly, the regression slopes fitted to the mean synovial P if versus time relation over 60 min for 200 M (0.02 Ϯ 0.01 cm H 2 O min Ϫ1 , n ϭ 5 joints) and 500 M cytochalasin D (Ϫ0.04 Ϯ 0.02, n ϭ 4) were not significantly different from zero (P Ն 0.14); only after the control injections did the mean P if drift slightly but significantly in a negative direction (slope Ϫ0.04 Ϯ 0.01 cm H 2 O min Ϫ1 , P ϭ 0.01, n ϭ 5). For subsynovium, none of the regression slopes for P if versus time were significantly different from zero (P Ն 0.18). Similar results were obtained in two joints injected with 1000 M cytochalasin D; there was no significant increase in the negativity of P if with time (n ϭ 2). By contrast, Berg et al. (2001) , observed that 1000 M cytochalasin D caused a progressive negative shift in P if with time in rat skin, by approximately Ϫ2.7 cm H 2 O over 60 min.
Half-Lives of Small Solutes in Joint Cavity in Vivo
Because no method was available to analyze the drug concentrations, intra-articular half-lives were determined for colored solutes of similar molecular size and diffusivity to latrunculin (395 Da) and cytochalasin D (508 Da); see Methods. The intra-articular halflives of acridine orange (370 Da), patent blue V (582 Da), and Evans blue (963 Da) in vivo were respectively 13.8 Ϯ 2.9 min (n ϭ 5), 24.2 Ϯ 2.7 min (n ϭ 2), and 55.0 min (n ϭ 1). The half-lives correlated significantly with molecular mass (Pearson's r ϭ 0.93, P Ͻ 0.001). On the basis of these half-lives it is likely that the intra-articular concentration of the drugs fell substantially below the cited nominal concentrations over the 30-min study intervals in vivo.
Half-Lives Post Mortem
When clearance measurements were made in the contralateral joint post mortem, the intra-articular halflives of acridine orange and patent blue V increased by 66 -107%, to 22.9 Ϯ 9.5 min (n ϭ 3) and 50.2 min (n ϭ 1), respectively. The difference between the paired results in vivo and post mortem indicated that small solutes are cleared partly into the microcirculation and partly by diffusion into the periarticular tissue (P ϭ 0.08, n ϭ 4, paired t test). Clearance from the cavity was calculated as intra-articular volume ϫ 0.693/half-life. The difference between the clearance of acridine orange in vivo and post mortem was 55 Ϯ 5 l min Ϫ1 . Since acridine orange is a small, rapidly diffusible molecule that is soluble in both lipid and water (Budavari, 1996) , and since fenestrated capillaries have a very high permeability to such solutes, its clearance by synovial capillaries is likely to be partly flow-limited. The above result may thus provide a minimal estimate of synovial microvascular perfusion, namely, Ն55 l min Ϫ1 (see Discussion).
Effect of Cytochalasin on Plasma ␥-globulin Permeation into the Joint Cavity
If the effect of cytochalasin on filtration is caused by endothelial gap formation, as inferred from studies in vitro (see Introduction), cytochalasin should also increase the permeation of large plasma proteins into the joint cavity. To test this, the net flux of native ␥-globulin into a pair of joint cavities injected with control solution and 100 M cytochalasin D solution, respectively, was analyzed; see Methods. Cytochalasin increased the net ␥-globulin flux into the joint cavity from 0.73 mg h Ϫ1 (control) to 1.74 mg h Ϫ1 . When normalized by the ␥-globulin concentration in plasma from the marginal ear vein, the corresponding clearances of plasma globulin into the joint cavity were 63 l h Ϫ1 (control) and 133 l h Ϫ1 (cytochalasin-treated). A more extensive study using labeled bovine albumin showed that intra-articular cytochalasin increases the plasma clearance of albumin into rabbit knee joints (Poli and Levick, 2000) .
DISCUSSION
The principle positive findings were that both cytochalasin and latrunculin caused large increases in pressure and fluid filtration into the joint cavity in vivo and that cytochalasin increased the permeation of plasma ␥-globulin into the joint cavity. The EC 50 value for these effects was higher than that for cultured endothelia in vitro, but this may be due partly to the short intra-articular half-life of the drug. Even so, near maximal effects were observed at 100 -200 M cytochalasin, which is almost an order of magnitude lower than the concentration of 1 mM used by Berg et al. (2001) to demonstrate statistically significant changes in rat skin.
Endothelial Origin of Increased Permeation of Macromolecules and Fluid
The increased permeation of ␥-globulin into the joint, and of intravascular labeled albumin (Poli and Levick, 2000) , indicates a major increase in microvascular permeability. This may be due to endothelial gap formation, which is a well-documented response in vitro (Shasby et al., 1982; Alexander et al., 1988; Haselton et al., 1989; Holda and Blatter, 1997; Kevil et al., 1998) . In support of this, intravascular injections of Monastral blue in vivo demonstrated that intra-articular cytochalasin induces spotty leakage in synovial microvessels (Poli et al., 2001) . The high filtration rates could likewise be due to endothelial gap formation; gaps are expected to raise the endothelial conductance and probably reduce the albumin reflection coefficient, which is normally Ն0.8 in synovial capillaries (Knight et al., 1988) . A spatially distributed model of trans-synovial flow predicts substantial increases in filtration into the joint cavity in response to moderate reductions in effective colloid osmotic pressure across the synovial endothelium (Levick, 1991;  Fig. 3C ).
The filtration rates induced by cytochalasin may represent a substantial fraction of the synovial plasma flow. Synovial microvascular perfusion is an important parameter for which there is scanty information. The estimate of Ն55 l min Ϫ1 , based on acridine orange clearance in vivo versus post mortem, is of similar magnitude to that inferred from the mean synovial capillary volume (Levick and McDonald, 1989a, b) divided by mean transit time (Funk et al., 1995) , namely, 64 -128 l min Ϫ1 in the rabbit knee; the latter estimate corresponds to a plasma flow of 45-90 l min Ϫ1 for a dynamic microvascular hematocrit of 0.3. If the synovial plasma flow is, then, of the order 55 l min Ϫ1 , the filtration rates into the joint cavity of 6.6 -12.5 l min Ϫ1 in response to 200 M cytochalasin D represent filtration fractions of 12-23%. Although the filtration fraction would be reduced if cytochalasin D raised the synovial blood flow, a pilot study using N 2 O wash-in/washout and an intra-articular N 2 Osensitive electrode provided no evidence of a hyperemic response to cytochalasin.
Since the primary action of cytochalasin and latrunculin is to disrupt actin microfilaments, the results indicate that F-actin is an important structural element in the fenestrated endothelial barrier in vivo. This may be related to the fact that the junctional proteins, such as the cadherin-catenin complex, are restrained spatially in the fluid lipid bilayer by linkages through ␣-actinin to the actin cytoskeleton (Dejana et al., 1995) . The results do not exclude the formation of transcellular as opposed to intercellular gaps (Michel and Curry, 1999) . Cytoskeleton disassembly can have additional, less direct effects (Janmey, 1999) . For example, F-actin disassembly in endothelium but not fibroblasts impairs capacitative Ca 2ϩ entry and impairs receptor-mediated Ca 2ϩ entry in both cell types (Holda and Blatter, 1997; Ribeiro et al., 1997) .
Rapidity and Reversibility of Drug Action
The turnover of F-actin is rapid in many cultured cell lines (Symons and Mitchison, 1991) , and cytochalasin in vitro increases the permeability of an arterial endothelial monolayer to dextran by fourfold in 30 min (Kevil et al., 1998) . The impressively rapid effects of cytochalasin observed in the present experiments in vivo (Fig. 1) may be due to a very fast turnover of F-actin in the fenestrated endothelium. Studies in vitro show too that the cytochalasin-induced hyperpermeability of monolayers can be reversed within an hour (Shasby et al., 1982; Haselton et al., 1989 ). The present experiments, which had a time resolution of minutes, showed that reversal begins within minutes of drug washout in vivo (Fig. 3) . This may again be the result of a rapid turnover and rebuilding of filamentous actin in synovial endothelium.
Does Cytochalasin Treatment Affect the Synovial Interstitial Matrix Too?
Transport between the circulation and joint cavity involves two barriers in series, the endothelium and synovial intercellular matrix, but several lines of evidence point to the endothelium rather than the interstitial layer as the primary responder, as follows. (i) The effect of cytochalasin on P j was prevented by circulatory arrest (Fig. 1 and 4) . (ii) Endothelium is the chief site of resistance to plasma protein permeation, and the reflection of plasma protein by the interstitial layer is negligible (Scott et al., 2000a) . (iii) Studies using Monastral blue show the development of endothelial leaks (Poli et al., 2001) . (iv) Cytochalasin increases the permeability of endothelial monolayers to albumin (Shasby et al., 1982; Biffl et al., 1995; Lee et al., 1998) .
Nevertheless, the findings of Berg et al. (2001) in rat skin introduced the possibility that cytochalasin treatment might also affect the interstitial matrix. If the synoviocyte actin cytoskeleton "braces" the matrix through integrin-collagen linkages, as postulated in rat skin, then cytochalasin treatment could in principle induce a more negative interstitial fluid pressure. The servonull micropipette measurements of interstitial pressures post mortem showed, however, that cytochalasin had no more effect on synovial or subsynovial interstitial fluid pressure than did control solution. Nothing resembling the extra Ϫ2.7 cm H 2 O interstitial pressure observed in rat skin post mortem (Berg et al., 2001) was detected in the present study. Likewise the effect of cytochalasin or latrunculin on intra-articular pressure post mortem was no different from that of vehicle (Fig. 4) , even when the injectate volume was only 10 l. The reasoning behind the intra-articular study was that any increase in the swelling tendency of synovial interstitium will cause the absorption of some intra-articular fluid post mortem and thus reveal itself by a fall in intra-articular pressure. The extent to which intra-articular pressure can be expected to mirror changes in periarticular swelling pressure depends on the relative volume and compliance of the synovial cavity and the periarticular tissue. Calculations using estimates of compartment volumes and compliance from Knight and Levick, (1982) , Levick and McDonald (1989a, b) , Price et al. (1996) , and Scott et al. (2000b) indicate that if the synovium and subsynovium developed an extra Ϫ2.7 cm H 2 O swelling pressure, the intra-articular pressure would change by Ϫ1.6 cm H 2 O, given an injection volume of 10 l at subatmospheric joint pressure (the optimal conditions for detecting the putative effect). Despite its inferred detectability, no such response was seen. The results, therefore, provided no support for the hypothesis that in rabbit synovium the actin cytoskeleton of the fibroblasts (synoviocytes) directly influences the matrix fluid pressure.
To summarize, the study showed that endothelial F-actin has a major role in determining the normal synovial microvascular resistance to fluid filtration and plasma ␥-globulin permeation. F-actin disruption is thus a potential factor in the link between proinflammatory mediators and the formation of arthritic joint effusions. The results provided no support for the hypothesis that synoviocyte F-actin also influences the swelling tendency of synovial matrix and hence its hydration and permeability.
